RecruitingNot Applicable

Biomarkers in Transplant Recipients to Improve Outcomes

United States1,200 participantsStarted 2005-03

Plain-language summary

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Recipients of abdominal, thoracic and bone marrow allografts that are receiving inpatient and outpatient follow-up with routine laboratory tests at the University of Pittsburgh Medical Center. * All Ages * Subject or parents are able to read and understand the informed consent Exclusion Criteria: * Subjects and/or their parents who are unable to read and understand informed consent.

What they're measuring

Rejection

Timeframe: 90 day post transplantation (clinical severity)

Trial details

NCT IDNCT01163578

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-03

Contact for this trial

Morgan L Paul, BSN

412-692-8472 Morgan.Paul2@upmc.edu

View on ClinicalTrials.gov More Solid Organ Transplantation trials